TY - JOUR
T1 - Neurological injury in adults treated with extracorporeal membrane oxygenation
AU - Mateen, Farrah J.
AU - Muralidharan, Rajanandini
AU - Shinohara, Russell T.
AU - Parisi, Joseph E.
AU - Schears, Gregory J.
AU - Wijdicks, Eelco F.M.
PY - 2011/12
Y1 - 2011/12
N2 - Background: Extracorporeal membrane oxygenation (ECMO) may be urgently used as a last resort form of life support when all other treatment options for potentially reversible cardiopulmonary injury have failed. Objective: To examine the range and frequency of neurological injury in ECMO-treated adults. Design: Retrospective clinicopathological cohort study. Setting: Mayo Clinic, Rochester, Minnesota. Patients: A prospectively collected registry of all patients 15 years or older treated with ECMO for 12 or more hours from January 2002 to April 2010. Intervention: Patients were analyzed for potential risk factors for neurological events and death using logistic regression and Cox proportional hazards models. Main Outcome Measures: Neurological diagnosis and/or death. Results: A total of 87 adults were treated (35 female [40%]; median age, 54 years [interquartile range, 31]; mean duration of ECMO, 91 hours [interquartile range, 100]; overall survival ≲γτ∀7 days after ECMO, 52%). Neurological events occurred in 42 patients who received ECMO (50%; 95% confidence interval [CI], 39%-61%). Diagnoses included subarachnoid hemorrhage, ischemic watershed infarctions, hypoxic-ischemic encephalopathy, unexplained coma, and brain death. Death in patients who received ECMO who did not require antecedent cardiopulmonary resuscitation was associated with increased age (odds ratio,1.24 per decade; 95% CI, 1.03- 1.50; P=.02) and lower minimum arterial oxygen pressure (odds ratio, 0.79; 95% CI, 0.68-0.92; P=.03). Although stroke was rarely diagnosed clinically, 9 of 10 brains studied at autopsy demonstrated hypoxic-ischemic and hemorrhagic lesions of vascular origin. Conclusion: Severe neurological sequelae occur frequently in adult ECMO-treated patients with otherwise reversible cardiopulmonary injury (conservative estimate, 50%) and include a range of potentially fatal neurological diagnoses that may be due to the precipitating event and/or ECMO treatment.
AB - Background: Extracorporeal membrane oxygenation (ECMO) may be urgently used as a last resort form of life support when all other treatment options for potentially reversible cardiopulmonary injury have failed. Objective: To examine the range and frequency of neurological injury in ECMO-treated adults. Design: Retrospective clinicopathological cohort study. Setting: Mayo Clinic, Rochester, Minnesota. Patients: A prospectively collected registry of all patients 15 years or older treated with ECMO for 12 or more hours from January 2002 to April 2010. Intervention: Patients were analyzed for potential risk factors for neurological events and death using logistic regression and Cox proportional hazards models. Main Outcome Measures: Neurological diagnosis and/or death. Results: A total of 87 adults were treated (35 female [40%]; median age, 54 years [interquartile range, 31]; mean duration of ECMO, 91 hours [interquartile range, 100]; overall survival ≲γτ∀7 days after ECMO, 52%). Neurological events occurred in 42 patients who received ECMO (50%; 95% confidence interval [CI], 39%-61%). Diagnoses included subarachnoid hemorrhage, ischemic watershed infarctions, hypoxic-ischemic encephalopathy, unexplained coma, and brain death. Death in patients who received ECMO who did not require antecedent cardiopulmonary resuscitation was associated with increased age (odds ratio,1.24 per decade; 95% CI, 1.03- 1.50; P=.02) and lower minimum arterial oxygen pressure (odds ratio, 0.79; 95% CI, 0.68-0.92; P=.03). Although stroke was rarely diagnosed clinically, 9 of 10 brains studied at autopsy demonstrated hypoxic-ischemic and hemorrhagic lesions of vascular origin. Conclusion: Severe neurological sequelae occur frequently in adult ECMO-treated patients with otherwise reversible cardiopulmonary injury (conservative estimate, 50%) and include a range of potentially fatal neurological diagnoses that may be due to the precipitating event and/or ECMO treatment.
UR - http://www.scopus.com/inward/record.url?scp=83455225220&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=83455225220&partnerID=8YFLogxK
U2 - 10.1001/archneurol.2011.209
DO - 10.1001/archneurol.2011.209
M3 - Article
C2 - 21825216
AN - SCOPUS:83455225220
SN - 0003-9942
VL - 68
SP - 1543
EP - 1549
JO - Archives of neurology
JF - Archives of neurology
IS - 12
ER -